Interaction of Poly(butylcyanoacrylate) Nanoparticles with the Blood-Brain Barrier in vivo and in vitro

References

• Abbott N. J., Couraud P. O., Roux F., Begley D. J. Studies on an immortalised brain endothelial cell line: characterisation, permeability and transport. New Concepts of a Blood-Brain Barrier, J. Greenwood, D. J. Begley, M. B. Segal. Plenum Press, New York 1995; 239–249
   Google Scholar
• Alyautdin R. N., Gothier D., Petrov V., Kharkevich D., Kreuter J. Analgesic activity of the hexapeptide dalargin on the surface of polysorbate 80-coated poly(butylcyanoacrylate) nanoparticles. Eur. J. Biopharm 1995; 41: 44–48
   Web of Science ®Google Scholar
• Alyautdin R. N., Petrov V. E., Langer K., Berthold A., Kharkevich D. A., Kreuter J. Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Pharmaceutical Res 1997; 14: 325–328
   PubMed Web of Science ®Google Scholar
• Araujo L., Löbenberg R., Kreuter J. Influence of the surfactant concentration on the body distribution of nanoparticles. J. Drug Target 1999; 5: 373–385
   Google Scholar
• Begley D. J. The interaction of some centrally active drugs with the blood-brain barrier and circumventricular organs. Prog. in Brain Res 1992; 91: 163–169
   PubMed Web of Science ®Google Scholar
• Begley D. J., Lechardeur D., Chen Z. D., Rollinson C., Bardoul M., Roux F., Scherman D., Abbott N. J. Functional expression of P-glycoprotein in an immortalised cell line of rat brain endothelial cells, RBE4. J. Neurochem 1996; 67: 988–995
   PubMed Web of Science ®Google Scholar
• Borchard G., Audus K. L., Shi F., Kreuter J. Uptake of poly(methylmethacrylate)-nanoparticles by bovine brain microvessel endothelial cell monolayers after coating with surfactants. Int. J. Pharm 1994; 110: 29–35
   Web of Science ®Google Scholar
• Butt A. M., Jones H. C., Abbott N. J. Electrical resistance across the blood-brain barrier in the anaesthetised rat. J. Physiol. (London) 1990; 429: 47
   Google Scholar
• Cremer J. E., Seville M. P. Regional brain blood flow, blood volume, and haematocrit values in the adult rat. J. Cereb. Blood Flow and Metab 1983; 3: 254–256
   PubMed Web of Science ®Google Scholar
• Crone C., Oleson S. P. Regulation of ion permeability in frog brain microvascular endothelium. Brain. Res 1982; 241: 49
   PubMed Web of Science ®Google Scholar
• Dixon S. J., Pitaru S., Bhargava U., Aubin J. E. Membrane blebbing is associated with Ca2+ -activated hyperpolarizations induced by serum and α2-macroglobulin. J. Cell. Physiol 1987; 132: 215–225
   PubMedGoogle Scholar
• Durieu-Trautman O., Fédérici C., Créminon C., Fiognant-Chaverot N., Roux F., Claire N., Strosberg A. D., Couraud P. O. Nitric oxide and endothelin secretion by brain microvessel endothelial cells: regulation by cyclic nucleotides. J. Cell Physiol 1993; 155: 104–111
   PubMed Web of Science ®Google Scholar
• Fenart L., Casanova A., Dehouck B., Duhem C., Slupek S., Cecchelli R., Betbeder D. Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier. J. Pharmacol. Exp Therap 1999; 291: 1017–1022
   PubMed Web of Science ®Google Scholar
• Fenstermacher J. D., Gross P., Sposito N., Acuff V., Pettersen S., Gruber K. Structural and functional variations in capillary systems within the brain. Ann. N.Y. Acad, Sci 1988; 529: 21–30
   PubMedGoogle Scholar
• Friese A., Seiler E., Quack G., Lorenz B., Kreuter J. Enhancement of the duration of the antinoicieptive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release delivery system. Eur. J. Pharm. Biopharm 2000; 49: 103–109
   PubMed Web of Science ®Google Scholar
• Gottesman M. M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann. Rev. Biochem 1993; 62: 682–684
   Google Scholar
• Gulyaev A. E., Gelperina S. E., Skidan I. N., Antropov A. S., Kivman G. Y., Kreuter J. Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles. Pharm. Res 1999; 16: 1564–1569
   PubMed Web of Science ®Google Scholar
• Kreuter J., Alyautdin R. N., Kharkevich D., Ivanov A. A. Passage of peptides through the blood-brain barrier with colloidal polymer particles. Brain Res 1995; 674: 171–174
   PubMed Web of Science ®Google Scholar
• Kreuter J., Petrov V. E., Kharkevich D. A., Alyautdin R. N. Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood-brain barrier using surfactant-coated nanoparticles. J. Contr. Rel 1997; 49: 81–87
   Web of Science ®Google Scholar
• Olivier J. C., Fenart L., Chauvet R., Pariat C., Cecchelli R., Couet W. Indirect evidence that drug brain targeting using polysorbate-80 coated polybutylcyanoacrylate nanoparticles is related to toxicity. Pharm. Res 1999; 16: 1836–1841
   PubMed Web of Science ®Google Scholar
• Pardridge W. M. Peptide Drug Delivery to the Brain. Raven Press, New York 1991; 52–53
   Google Scholar
• Ramge P. Untersuchungen zur Überwindung der Blut-Hirn-Shranke mit Hilfe von Nanopartikeln. University of Frankfurt am Main. Ph. D. Thesis, Shaker Verlag, Aachen 1999; 93–95
   Google Scholar
• Ramge P., Kreuter J., Lemmer B. Circadian phase-dependent antinociceptive reaction in mice after i.v. injection of dalargin-loaded nanoparticles determined by the hot-plate test and the tail flick test. Chronobiol. Int 1999; 17: 767–777
   Google Scholar
• Ramge P., Unger R. E., Oltrogge J., Zenker D., Begley D., Kreuter J. Polysorbate-80 coating enhances uptake of polybutylcyanoacrylate (PBCA)-nanoparticles by human and bovine primary brain capillary endothelial cells. Eur. J. Neuroscience 2000; 12: 1931–1940
   PubMed Web of Science ®Google Scholar
• Roux F., Durieu-Trautman O., Chaverot N., Claire M., Mailly P., Bourre J. M., Strosberg A. D., Couraud P. O. Regulation of gamma-glutamyl transpeptidase and alkaline phospahatase activites in immortalised rat brain micovessel endothelial cells. J. Cell Physiol 1991; 159: 101–113
   Google Scholar
• Schinkel A., Wagenaar E., van Deemter L., Mol C. A.A.M., Borst P. P-glycoprotein in the brain of mice influences the brain penetration of many drugs. J. Clin Invest 1996; 97: 2517–2524
   PubMed Web of Science ®Google Scholar
• Schröder U., Sabel B. A. Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of I.V. dalargin injections. Brain. Res 1996; 710: 121–124
   PubMed Web of Science ®Google Scholar
• Schröder U., Schroder H., Sabel B. A. Body distributionn of 3H-labelled darargin bound to poly(butyl cyanoacrylate) nanoparticles after i.v. injections to mice. Life Sciences 2000; 66: 495–502
   PubMed Web of Science ®Google Scholar